Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS BBG US Liquid Corp 1-5 UCITS ETF USD dis
LU1048314949 · LU1048314949 · USD · domicile Luxembourg
Bonds · Corporate USD · 1-5 years · North AmericaSFDR art. 6
Index tracked: Bloomberg US Liquid Corporates 1-5 Year Total Return
- TER
- 0.16%+ trans. 0.04%
- Fund size
- 220 m EUR
- Tracking difference
- −0.21%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingsemi-annual
- Duration
- 3.06 yrsmedium (3–7 years)
Launch 1 Dec 2014 · costs from the KID as of 2 Sept 2026 · 0 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the Bloomberg US Liquid Corporates™ 1-5 Year Index (Total Return) using a stratified approach (stratified sampling strategy) by investing in a representative sample of components of the index selected by the portfolio manager using a 'portfolio optimisation' technique. The proportionate exposure by the Fund to the component securities will be substantially achieved either through direct investment or through the use of derivatives or through a combination of both…
Performance since series start (in euro) — base 100
1 Dec 2014 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +2.4% |
| 3 years | +7.7% |
| 5 years | +13.2% |
| 10 years | +22.9% |
| Since series start | +43.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 3.62% | 4.19% | 4.08% |
| Max drawdown | −4.48% | −4.48% | −11.54% |
| Sharpe | -1.41 | -0.67 | -1.05 |
| Sortino | -1.51 | -0.74 | -1.22 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1048314949 · LU10483149491
RebalixLU1048314949 · LU1048314949 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +7.08% | +7.25% | −0.18% |
| 2024 | +4.50% | +4.71% | −0.21% |
| 2023 | +6.29% | +6.53% | −0.23% |
| 2022 | −6.39% | −6.26% | −0.13% |
| 2021 | −0.94% | −0.77% | −0.17% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.6247 USD (4.61% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.6247 | — |
| 2025 | 2 | 0.7527 | +5.41% |
| 2024 | 2 | 0.6749 | +4.83% |
| 2023 | 2 | 0.4541 | +3.34% |
| 2022 | 2 | 0.1971 | +1.34% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 10.1%
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
CBUS5 · Borsa Italiana (ETFplus)
UEF7 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU1048314949
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1048314949
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1048314949 · LU10483149492